Clinical Trials in Georgia

Showing 6681-6700 of 19,050 trials

Effectiveness and Safety of the RIGHTEST Continuous Glucose Monitoring System for Blood Glucose Management in Persons With Diabetes Mellitus

NCT04838392

The purpose of this study is to evaluate the effectiveness and safety of the RIGHTEST Continuous Monitoring (CGM) System in adult population with diabetes mellitus.

Diabetes MellitusType 1 DiabetesType 2 Diabetes

Bionime Corporation150 participantsStarted Dec 2024

Guntersville, Alabama, United States • Tucson, Arizona, United States • Canoga Park, California, United States +10 more locations

COMPLETEDNA65 miles

ILUMIEN IV: OPTIMAL Percutaneous Coronary Intervention (PCI)

NCT03507777

The objective of this prospective, single-blind clinical investigation is to demonstrate the superiority of an Optical Coherence Tomography (OCT)-guided stent implantation strategy as compared to an angiography-guided stent implantation strategy in achieving larger post-PCI lumen dimensions and improving clinical cardiovascular outcomes in patients with high-risk clinical characteristics and/or with high-risk angiographic lesions.

Coronary Artery DiseaseCoronary StenosisAtherosclerosis+3 more

Abbott Medical Devices2,487 participantsStarted May 2018

Birmingham, Alabama, United States • Scottsdale, Arizona, United States • Burlingame, California, United States +87 more locations

Effectiveness and Safety of the RIGHTEST Continuous Glucose Monitoring System for Blood Glucose Management in Persons With Diabetes Mellitus

ILUMIEN IV: OPTIMAL Percutaneous Coronary Intervention (PCI)

Find Trials by Condition in Georgia

A Randomized Trial of Low-Dose Bevacizumab vs Laser for Type 1 ROP

Efficacy and Safety of Roxadustat for Treatment of Anemia in Participants With Lower Risk Myelodysplastic Syndrome With Low Red Blood Cell Transfusion Burden

Study to Evaluate the Efficacy and Safety of Once-Weekly Oral NBI-1065846 in the Treatment of Anhedonia in MDD

Trial to Learn About the Study Medicine (PF-07081532) and Rybelsus in People With Type 2 Diabetes and Separately PF-07081532 in People With Obesity

The clonoSEQ® Watch Registry

A Study of Ramucirumab Plus Pembrolizumab in Participants With Gastric or GEJ Adenocarcinoma, NSCLC, Transitional Cell Carcinoma of the Urothelium, or Biliary Tract Cancer

Investigation of Genetic Determinants of Capecitabine Toxicity

Effect of AEF0117 on Treatment-seeking Patients With Cannabis Use Disorder (CUD)

Seeded Cells on Matrix Plug Treating Crohn's Perianal Fistulas (STOMP-II)

A Study of AT13387 in Patients With Non-Small Cell Lung Cancer (NSCLC) Alone and in Combination With Crizotinib

A Study to Assess the Safety, Pharmacokinetics, and Antitumor Activity of Oral TACH101 in Participants With Advanced or Metastatic Cancer

A Dose Escalation Study Evaluating the Safety and Tolerability of GDC-0032 in Participants With Locally Advanced or Metastatic Solid Tumors or Non-Hodgkin's Lymphoma (NHL) and in Combination With Endocrine Therapy in Locally Advanced or Metastatic Hormone Receptor-Positive Breast Cancer

A Study Of Avelumab In Combination With Other Cancer Immunotherapies In Advanced Malignancies (JAVELIN Medley)

Continued Access to the Recell® Device for Treatment of Acute Burn Injuries

Tagraxofusp in Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm or Acute Myeloid Leukemia

Episealer® Knee System IDE Clinical Study

A Study to Evaluate the Effectiveness and Safety of SKI-O-703 in Patients Experiencing Active Rheumatoid Arthritis Despite Treatment With Conventional Therapies.

Immune Response to SARS-CoV-2 (COVID-19) Vaccines in Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma